Basic Information

Symbol
circUBAP2
RNA Class
circRNA
Alias
Ubiquitin Associated Protein 2 KIAA1491 RNA Polymerase II Degradation Factor UBAP2 Ubiquitin-Associated Protein 2 BA176F3.5 FLJ22435 UBAP-2 AD-012 Protein
Location (GRCh37)
9:33817819-34048885 UCSC Genome Browser
Location (GRCh38)
9:33817821-34048887
UCSC Genome Browser Search in Marker Scope
Host gene
UBAP2
Host category
mRNA
Forensic tag(s)
Sudden cardiac death diagnosis
External database
circbank

Transcripts

ID Type Location (GRCh37) Location (GRCh38) Length GC content
hsa_UBAP2_0021700 Intron-Exon-Intron chr9:33998785-34025481 chr9:33998787-34025483 78 nt 0.3974
hsa_UBAP2_0021400 Intron-Exon-Intron chr9:33998785-34032906 chr9:33998787-34032908 250 nt 0.4000
hsa_UBAP2_0021800 Intron-Exon-Intron chr9:33998785-34032910 chr9:33998787-34032912 114 nt 0.5702
hsa_chr9_0415800 Intergenic-Intergenic chr9:34000041-34013810 chr9:34000043-34013812 250 nt 0.3960
hsa_chr9_0415900 Intergenic-Intergenic chr9:34002471-34004418 chr9:34002473-34004420 1948 nt 0.4682
hsa_chr9_0416000 Intergenic-Intergenic chr9:34003145-34006167 chr9:34003147-34006169 250 nt 0.4080
hsa_chr9_0416100 Intergenic-Intergenic chr9:34003307-34013643 chr9:34003309-34013645 250 nt 0.3400
hsa_chr9_0416300 Intergenic-Intergenic chr9:34003465-34005196 chr9:34003467-34005198 1732 nt 0.4752
hsa_chr9_0416200 Intergenic-Intergenic chr9:34003465-34008898 chr9:34003467-34008900 250 nt 0.4280
hsa_chr9_0416400 Intergenic-Intergenic chr9:34003813-34004418 chr9:34003815-34004420 606 nt 0.4125
Showing 231 to 240 of 263 entries
Forensic Context

A review of literature indicates that the circUBAP2 is an oncogenic circular RNA upregulated in osteosarcoma patient samples, where its high expression is correlated with lower overall survival and promotes tumor growth while inhibiting apoptosis [Di Agostino et al. DOI:10.3389/fcell.2020.00389]. A study in human patients with heart failure after acute myocardial infarction demonstrated that the expression level of the circUBAP2 was not significantly different between patients with sacubitril/valsartan resistance and non-resistant patients in quantitative real-time PCR validation [Su et al. DOI:10.1016/j.ejphar.2023.175547].